Please assess the completion status of the following clinical trial:

Trial Title: STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic renal anemia;~* Continuous stable intravenous maintenance epoetin therapy during previous month;~* Regular long-term hemodialysis therapy with the same mode of dialysis for previous 3 months.~Exclusion Criteria:~* Transfusion of red blood cells during previous 2 months;~* Poorly controlled hypertension, that is, sitting blood pressure exceeding 170/100 millimeter of mercury (mmHg) despite medication;~* Significant acute or chronic bleeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).